Skip to main content
FDA Updates
Brukinsa Approved for Marginal-Zone Lymphoma and for Waldenström’s Macroglobulinemia
Read More
Online First
FDA Updates
Nivolumab First Immunotherapy Approved for Adjuvant Treatment of Urothelial Carcinoma
Read More
Online First
FDA Updates
Jemperli Another Therapy Approved for Patients with dMMR Recurrent or Advanced Solid Tumors
Read More
Online First
FDA Updates
Lenvima plus Keytruda a New Combination Approved for Advanced Renal-Cell Carcinoma
Read More
Meeting Highlights
Multiple Myeloma, ASCO Highlights
New CAR T-Cell Therapy Produces Durable Responses in Relapsed or Refractory Multiple Myeloma
Wayne Kuznar
Wayne Kuznar
Read More
IWTI Best Practices in GU Navigation
Interview with the Innovators
Quality of Life with Combination Therapy in Advanced Renal-Cell Cancer
Megan Price, MSN, APRN, FNP-C, Virginia Seery, MSN, RN, ANP-BC, AOCNP, Laura Wood, RN, MSN, OCN
Read More
FDA Updates
Pylarify Second Radioactive Imaging Drug FDA Approved for PSMA-Positive Prostate Cancer
Read More
Meeting Highlights
Biosimilars, ASCO Highlights
Rapid Biosimilar Adoption Possible in Community Oncology Practice
Chase Doyle
Chase Doyle
Read More
Meeting Highlights
Lung Cancer, ASCO Highlights
Atezolizumab Extends Disease-Free Survival in PD-L1−Positive Early-Stage NSCLC
Phoebe Starr
Phoebe Starr
Read More
IWTI Best Practices in GU Navigation
Interview with the Innovators
The Impact of Real-World Data on Efficacy and Safety of Agents for Advanced Renal-Cell Cancer
Megan Price, MSN, APRN, FNP-C, Virginia Seery, MSN, RN, ANP-BC, AOCNP, Laura Wood, RN, MSN, OCN
Read More
Page 83 of 196
Results 821 - 830 of 1954